Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

BSPG Laboratories VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (Brains Bio), a global leader in natural, GMP-compliant cannabinoid Active Pharmaceutical Ingredients (APIs), announces the expansion of its industry-leading offering. Cannabinol (CBN) is available as an EU-GMP certified API, D9-Tetrahydrocanabinol (THC) is in a solid crystalline

Read More

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

BSPG Laboratories Brains Bioceutical Corps. wholly-owned subsidiary BSPG Laboratories in Sandwich Kent VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (Brains Bio), a global leader in natural, GMP-compliant cannabinoid Active Pharmaceutical Ingredients (APIs), announces the expansion of its industry-leading offering. Cannabinol (CBN) is available as an

Read More

Quantexa Recognized as Category Leader in Chartis’ 2024 AML Transaction Monitoring Solutions Report

The data, analytics, and AI software provider achieved “best-in-class” ratings for its anti-money laundering capabilities in data integration, modelling and workflow LONDON, Dec. 16, 2024 (GLOBE NEWSWIRE) — Quantexa, a leading provider of Decision Intelligence solutions for the public and private sectors, today announced recognition in Chartis’ RiskTech Quadrant Update

Read More

Quantexa Recognized as Category Leader in Chartis’ 2024 AML Transaction Monitoring Solutions Report

The data, analytics, and AI software provider achieved “best-in-class” ratings for its anti-money laundering capabilities in data integration, modelling and workflow LONDON, Dec. 16, 2024 (GLOBE NEWSWIRE) — Quantexa, a leading provider of Decision Intelligence solutions for the public and private sectors, today announced recognition in Chartis’ RiskTech Quadrant Update for anti-money laundering

Read More

FLUX FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Flux Power Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FLUX

NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flux Power Holdings, Inc. (NASDAQ: FLUX) between November 11, 2022 and September 30, 2024, both dates inclusive (the “Class Period”), of the important December 31, 2024 lead

Read More

FLUX FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Flux Power Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – FLUX

NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flux Power Holdings, Inc. (NASDAQ: FLUX) between November 11, 2022 and September 30, 2024, both dates inclusive (the “Class Period”), of the important December 31, 2024 lead plaintiff deadline in

Read More